GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lantheus Holdings Inc (NAS:LNTH) » Definitions » Shiller PE Ratio

Lantheus Holdings (Lantheus Holdings) Shiller PE Ratio : 70.49 (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lantheus Holdings Shiller PE Ratio?

As of today (2024-04-28), Lantheus Holdings's current share price is $65.56. Lantheus Holdings's E10 for the quarter that ended in Dec. 2023 was $0.93. Lantheus Holdings's Shiller PE Ratio for today is 70.49.

The historical rank and industry rank for Lantheus Holdings's Shiller PE Ratio or its related term are showing as below:

LNTH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 56.86   Med: 206.84   Max: 904.78
Current: 70.2

During the past years, Lantheus Holdings's highest Shiller PE Ratio was 904.78. The lowest was 56.86. And the median was 206.84.

LNTH's Shiller PE Ratio is ranked worse than
88.01% of 517 companies
in the Drug Manufacturers industry
Industry Median: 24.4 vs LNTH: 70.20

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lantheus Holdings's adjusted earnings per share data for the three months ended in Dec. 2023 was $1.470. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.93 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lantheus Holdings Shiller PE Ratio Historical Data

The historical data trend for Lantheus Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lantheus Holdings Shiller PE Ratio Chart

Lantheus Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 586.08 66.39

Lantheus Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 586.08 364.43 193.77 99.28 66.39

Competitive Comparison of Lantheus Holdings's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lantheus Holdings's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Shiller PE Ratio falls into.



Lantheus Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lantheus Holdings's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=65.56/0.93
=70.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantheus Holdings's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Lantheus Holdings's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.47/129.4194*129.4194
=1.470

Current CPI (Dec. 2023) = 129.4194.

Lantheus Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.071 99.695 -0.092
201406 -0.060 100.560 -0.077
201409 -0.050 100.428 -0.064
201412 0.010 99.070 0.013
201503 0.020 99.621 0.026
201506 -1.290 100.684 -1.658
201509 0.180 100.392 0.232
201512 0.130 99.792 0.169
201603 0.340 100.470 0.438
201606 0.240 101.688 0.305
201609 0.130 101.861 0.165
201612 0.130 101.863 0.165
201703 0.110 102.862 0.138
201706 0.350 103.349 0.438
201709 0.220 104.136 0.273
201712 2.470 104.011 3.073
201803 0.210 105.290 0.258
201806 0.250 106.317 0.304
201809 0.240 106.507 0.292
201812 0.340 105.998 0.415
201903 0.250 107.251 0.302
201906 0.160 108.070 0.192
201909 0.120 108.329 0.143
201912 0.260 108.420 0.310
202003 0.080 108.902 0.095
202006 -0.160 108.767 -0.190
202009 -0.100 109.815 -0.118
202012 -0.050 109.897 -0.059
202103 0.130 111.754 0.151
202106 -0.390 114.631 -0.440
202109 -0.200 115.734 -0.224
202112 -0.590 117.630 -0.649
202203 0.610 121.301 0.651
202206 0.610 125.017 0.631
202209 0.860 125.227 0.889
202212 -1.740 125.222 -1.798
202303 -0.040 127.348 -0.041
202306 1.330 128.729 1.337
202309 1.880 129.860 1.874
202312 1.470 129.419 1.470

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lantheus Holdings  (NAS:LNTH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lantheus Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lantheus Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lantheus Holdings (Lantheus Holdings) Business Description

Traded in Other Exchanges
Address
201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Executives
Andrea Sabens officer: Chief Accounting Officer C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Marshall Robert J. Jr. officer: CFO and Treasurer C/O LANTHEUS MEDICAL IMAGING, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Paul Blanchfield officer: Chief Commercial Officer C/O LANTHEUS HOLDINGS, INC., 331, NORTH BILLERICA MA 01862
Mary Anne Heino director, officer: CEO and President C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA NY 01862
Daniel Niedzwiecki officer: See Remarks C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Minnie Baylor-henry director C/O SCPHARMACUETICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01803
Etienne Montagut officer: See Remarks C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Sam R Leno director C/O BOSTON SCIENTIFIC CORPORATION, ONE BOSTON SCIENTIFIC PLACE, NATICK MA 01760
Brian A Markison director 501 FIFTH STREET, BRISTOL TN 37620
Jean-claude Provost officer: Chief Medical Officer C/O LANTHEUS HOLDINGS, INC., 201 BURLINGTON RD, SOUTH BUILDING, BEDFORD MA 01730
Julie Mchugh director C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON MA 02110
Gerard Ber director C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, 33RD FLOOR, NEW YORK NY 10169
Carol Walker officer: Senior Vice President, Quality C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Ying Vivian Yao officer: Chief Human Resources Officer C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
John J. Bolla director C/O LANTHEUS MEDICAL IMAGING, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862